TTP is highly unlikely in this clinical scenario
In a patient with severe sepsis (necrotizing fasciitis, pneumonia, and Candida tropicalis sepsis), the thrombocytopenia and anemia are almost certainly due to sepsis-related consumptive coagulopathy and bone marrow suppression, not TTP. The low reticulocyte production index directly contradicts TTP, which characteristically shows brisk reticulocytosis from hemolysis.
Critical Distinguishing Features Against TTP
Why This is NOT TTP:
Low reticulocyte production index - This is the most important clue. TTP causes microangiopathic hemolytic anemia (MAHA) with vigorous bone marrow response and elevated reticulocyte counts 1, 2. Your patient has bone marrow suppression, which is typical of severe sepsis but incompatible with TTP.
Severe active infections present - While infections can rarely trigger TTP 3, 4, 5, 6, the constellation of necrotizing fasciitis, pneumonia, and fungal sepsis makes sepsis-induced thrombocytopenia and anemia far more likely 7, 8.
Markedly elevated CRP - Severe systemic inflammation from sepsis explains all findings. TTP patients typically have normal or only mildly elevated inflammatory markers unless there's concurrent infection 2.
What You Should Look For Instead:
Confirm sepsis-related thrombocytopenia:
- Check for schistocytes on peripheral smear - If absent or minimal, TTP is essentially ruled out 1, 2
- Lactate dehydrogenase (LDH) - Should be massively elevated in TTP from hemolysis 1
- Haptoglobin - Should be undetectable in TTP
- Direct antiglobulin test (Coombs) - Nearly always negative in TTP 2
- Coagulation studies - Normal PT/PTT in TTP but often abnormal in sepsis with DIC 7
If any doubt remains:
Send ADAMTS13 activity level immediately - This is the definitive test. TTP requires ADAMTS13 activity <10% 1, 2. However, do not delay treatment of sepsis while awaiting results.
Common Pitfall to Avoid:
Do NOT start plasma exchange empirically in this patient. The 2025 ISTH guidelines emphasize that TTP diagnosis requires severe ADAMTS13 deficiency (<10%) in the proper clinical context 1, 2. Starting TPE without confirming TTP diagnosis exposes the patient to unnecessary central line placement (with profound thrombocytopenia), plasma-related complications, and delays in addressing the actual problem—severe sepsis requiring source control and antimicrobials.
The Actual Diagnosis:
This patient has sepsis-induced thrombocytopenia with bone marrow suppression (explaining low reticulocyte production) 7, 8. The high D-dimer reflects sepsis-associated coagulopathy, possibly evolving DIC. Focus should be on:
- Aggressive source control (surgical debridement of necrotizing fasciitis)
- Appropriate antimicrobials for polymicrobial infection
- Supportive care for septic shock
Only if schistocytes are abundant AND LDH is markedly elevated should you even consider sending ADAMTS13 2. Even then, sepsis-associated thrombotic microangiopathy (not TTP) would be more likely 7.